Health Canada
- Status: approved
🇨🇦 Other atypical antipsychotic drugs in Canada
Other atypical antipsychotic drugs (Other atypical antipsychotic drugs) regulatory status in Canada.
Marketing authorisation
Other atypical antipsychotic drugs in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Other atypical antipsychotic drugs approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Other atypical antipsychotic drugs in Canada?
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. is the originator. The local marketing authorisation holder may differ — check the official source linked above.